This guidance will fully update the following:
Status In progress
Process STA
ID number 837

Provisional Schedule

Appeal 01 December 2017

Project Team

Project lead Jeremy Powell

Email enquiries


Companies sponsors Roche
Others Department of Health
  NHS England
  Welsh Government
Patient carer groups Action For Pulmonary Fibrosis
  Pulmonary Fibrosis Trust
Professional groups British Thoracic Society
  Royal College of Nursing
  Royal College of Physicians
  UK Clinical Pharmacy Association


Comparator companies Boehringer Ingelheim (nintedanib)
General commentators Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland


Key events during the development of the guidance:

Date Update
12 September 2017 Appeal
12 September 2017 Appeal
14 August 2017 NICE has received 2 appeals against the Final Appraisal Determination on this above technology. The appeal panel will convene on 12 September 2017 at NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester M1 4BT to hear oral representations from the appellants.
09 June 2017 - 23 June 2017 Final appraisal determination: 2
20 April 2017 Committee meeting: 3
24 January 2017 Appeal decision
02 December 2016 Appeal
02 December 2016 Appeal
17 October 2016 Appeal
16 September 2016 - 30 September 2016 Final appraisal determination
04 August 2016 Committee meeting: 2
03 June 2016 - 24 June 2016 Appraisal consultation: 1
05 May 2016 Committee meeting: 1
03 December 2015 Invitation to participate

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance